1.A Phase 2

2. Multi-center

3. Randomized

4. Open-label

5. Dose escalation study to determine safety of single (QD) and multiple (3 QD) doses of KAE609

6. Given to adults with uncomplicated Plasmodium falciparum malaria ongoing study.

We execute the activities aiming to promote health in Rwanda.

For more information, please send an email